USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Ibandronate Sodium Injection

BRIEFING

Ibandronate Sodium Injection. Because there is no existing USP monograph for this drug product, a new monograph based on validated methods of analysis is proposed. The proposal for this drug product which appeared in PF 46(4) [July–Aug. 2020] was canceled and is replaced with a new proposal.

  1. The liquid chromatographic procedure in the Assay is validated using the Allsep Anion brand of column with L23 packing. The typical retention time for ibandronic acid is about 12 min.

  2. The liquid chromatographic procedure in the Organic Impurities test is validated using the Inertsil C8-3 brand of column with L7 packing. The typical retention time for ibandronic acid is about 7 min.

 (SM3: R. Fales)

 Case ID—SUB-767

USP REFERENCE STANDARDS FOR PURCHASE

USP Ibandronate Sodium RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!